(Total Views: 321)
Posted On: 01/21/2021 1:42:01 PM
Post# of 653
$RLFTF Relief Announces Implementation of New Share Subscription Facility with Main Shareholder GEM
GENEVA, SWITZERLAND / ACCESSWIRE / January 21, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF)
("Relief" or the "Company"
, a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today announced that it has signed a binding agreement with the Company's main shareholder GEM Global Yield LLC SCS ("GEM" for the implementation of a new Share Subscription Facility ("SSF" in the amount of up to CHF 50 million.
GEM is Relief's longest standing shareholder, dating back to their initial investment in 2015, and currently owns over 1.3 billion shares of Relief common stock.
https://finance.yahoo.com/news/relief-announc...00895.html
GENEVA, SWITZERLAND / ACCESSWIRE / January 21, 2021 / RELIEF THERAPEUTICS Holding AG (SIX:RLF)(OTCQB:RLFTF)
("Relief" or the "Company"
, a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today announced that it has signed a binding agreement with the Company's main shareholder GEM Global Yield LLC SCS ("GEM" for the implementation of a new Share Subscription Facility ("SSF" in the amount of up to CHF 50 million. GEM is Relief's longest standing shareholder, dating back to their initial investment in 2015, and currently owns over 1.3 billion shares of Relief common stock.
https://finance.yahoo.com/news/relief-announc...00895.html
(1)
(0)
$MJ
